Cargando…
The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury
Autores principales: | Ahmed, Zubair, Tuxworth, Richard I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274214/ https://www.ncbi.nlm.nih.gov/pubmed/35818848 http://dx.doi.org/10.1002/ctm2.962 |
Ejemplares similares
-
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
por: Durant, Stephen T., et al.
Publicado: (2018) -
ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis
por: Tew, Ben Yi, et al.
Publicado: (2023) -
Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury
por: Taylor, Matthew J., et al.
Publicado: (2022) -
Pigment Epithelium-Derived Factor Promotes Axon Regeneration and Functional Recovery After Spinal Cord Injury
por: Stevens, Andrew R., et al.
Publicado: (2019) -
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
por: Davis, S. Lindsey, et al.
Publicado: (2022)